1 - 10 of 51 articles
TWO NEW drugs, apparently acting in different ways, may soon provide clinical options in treating multiple sclerosis.
Only a year ago there were no effective agents on the market to delay the course of autoimmune nerve demyelination. The Food and Drug Administration late in 1993 approved...
IN ITS BRIEF life span, the Human Genome Project has established a track record that many commercial industries might envy.
After 4 years, the ambitious international effort to map the estimated 100 000 genes in the human body is ahead of schedule and under budget. "We now have a very good human...
THE PRICE is right, the cost is reasonable, but in tomorrow's medical practice what will count is the effectiveness of the intervention in relation to the cost of providing it. A whole new science is springing up that is engaged in developing appropriate standards and ways to evaluate such...
TOMORROW marks the beginning of the third year for US military medicine's operation of the United Nations (UN) hospital in the former republic of Yugoslavia.
It was November 10, 1992, when an advance team of medical and support personnel from the 212th Mobile (US) Army Surgical Hospital (MASH)...
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.